Literature DB >> 14673202

The structural perspective on CDK5.

Marina Mapelli1, Andrea Musacchio.   

Abstract

Cyclin-dependent kinase 5 (CDK5) plays an essential role in the development of the central nervous system during mammalian embryogenesis. In the adult, CDK5 is required for the maintenance of neuronal architecture. Its deregulation has profound cytotoxic effects and has been implicated in the development of neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis. In this review, we concentrate on the regulation of CDK5 activity, privileging a structural perspective based on a decade of structural analyses of different members of the CDK family, including CDK2 and CDK5. We review the activation mechanism of CDK5 and discuss its differences and similarities with that of CDK2 and of the other members of the CDK family. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673202     DOI: 10.1159/000074617

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  7 in total

1.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

2.  Docking and 3D-QSAR modeling of cyclin-dependent kinase 5/p25 inhibitors.

Authors:  Zaheer Ul Haq; Reaz Uddin; Lam Kok Wai; Abdul Wadood; Nordin Haji Lajis
Journal:  J Mol Model       Date:  2010-08-05       Impact factor: 1.810

3.  Functional flexibility of human cyclin-dependent kinase-2 and its evolutionary conservation.

Authors:  Iveta Bártová; Jaroslav Koca; Michal Otyepka
Journal:  Protein Sci       Date:  2007-11-27       Impact factor: 6.725

Review 4.  An unusual member of the Cdk family: Cdk5.

Authors:  Fatema A Dhariwala; Medha S Rajadhyaksha
Journal:  Cell Mol Neurobiol       Date:  2008-01-08       Impact factor: 5.046

5.  Molecular basis of differential selectivity of cyclobutyl-substituted imidazole inhibitors against CDKs: insights for rational drug design.

Authors:  Soumya Lipsa Rath; Sanjib Senapati
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

6.  Novel rare variations in genes that regulate developmental change in N-methyl-d-aspartate receptor in patients with schizophrenia.

Authors:  Akane Yoshikawa; Fumichika Nishimura; Aya Inai; Yosuke Eriguchi; Masaki Nishioka; Atsuhiko Takaya; Mamoru Tochigi; Yoshiya Kawamura; Tadashi Umekage; Kayoko Kato; Tsukasa Sasaki; Kiyoto Kasai; Chihiro Kakiuchi
Journal:  Hum Genome Var       Date:  2018-02-01

Review 7.  CDK5: Key Regulator of Apoptosis and Cell Survival.

Authors:  Rabih Roufayel; Nimer Murshid
Journal:  Biomedicines       Date:  2019-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.